MRC1 and bladder transitional cell carcinoma: These negative correlations confirmed that DDR-d tumors with high adaptive immune response corresponded with those showing improved survival upon ICI treatments, including DNA polymerase carriers in BLCA, HNSC, and STAD, as well as MMR carriers in BLCA, SKCM, and COADREAD.